Nitric oxide- and EDHF-mediated arteriolar tone in uremia is unaffected by selective inhibition of vascular cytochrome P4502C9

被引:16
作者
Passauer, J
Pistrosch, F
Lässig, G
Herbrig, K
Büssemaker, E
Gross, P
Fleming, I
机构
[1] Univ Hosp Carl Gustav Carus, Dept Med, Div Nephrol, Dresden, Germany
[2] Goethe Univ Frankfurt, Inst Kardiovask Physiol, Vasc Signalling Grp, D-6000 Frankfurt, Germany
关键词
nitric oxide; endothelium-derived hyperpolarizing factor; sulfaphenazole; plethysmography;
D O I
10.1111/j.1523-1755.2005.00289.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background. Uremia is a state of endothelial dysfunction as demonstrated by a reduced agonist-induced endothelium-dependent vasodilatation. Recent studies suggest that an endothelial cytochrome P450 (CYP) epoxygenase (CYP 2C9) can modulate endothelium-dependent vasodilatation in two different ways: (1) by the production of epoxyeicosatrienoic acids (EETs), which elicit hyperpolarization and relaxation; and (2) by the release of oxygen-derived free radicals, which compromise the bioavailability of nitric oxide. We therefore determined whether one of these pathways is involved in endothelial dysfunction of uremia. Methods. Using venous occlusion plethysmography, we measured forearm blood flow (171317) in response to the intrabrachial infusion of acetylcholine (ACh; endothelium-dependent vasodilator 1, 5, 10, 50, 100, and 300 nmol/min) and sodium nitroprusside (SNP; endothelium-independent vasodilator; 2.5, 5 and 10 mu g/min) in 10 stable patients on hemodialysis (HD) and 9 healthy control subjects. In HD patients, ACh infusions were repeated together with sulfaphenazole (SPZ, 6 mg/min), a highly selective inhibitor of CYP 2C9 with and without concomitant blockade of the nitric oxide synthase (NOS) by N(omega)monomethyl L-arginine (L-NMMA, 16 mu mol/min). Results. Endothelium-dependent vasodilatation to ACh was reduced in HD compared to control subjects (P = 0.002), indicating endothelial dysfunction in the patients examined. Endothelium-independent vascular responses to SNP were attenuated in HD, but not significantly different to control. SPZ failed to modulate both baseline FBF and Ach-induced vasodilatation in HD. Furthermore, SPZ had no effect on baseline FBF and ACh-mediated vasodilatation in the presence of L-NMMA in HD. Conclusion. Our results do not support a major role for CYP 2C9-derived products in the regulation of arteriolar tone in early endothelial dysfunction of uremic subjects.
引用
收藏
页码:1907 / 1912
页数:6
相关论文
共 22 条
[1]  
Annuk M, 2001, J AM SOC NEPHROL, V12, P2747, DOI 10.1681/ASN.V12122747
[2]   Endothelium-derived hyperpolarizing factor in human internal mammary artery is 11,12-epoxyeicosatrienoic acid and causes relaxation by activating smooth muscle BKCa channels [J].
Archer, SL ;
Gragasin, FS ;
Wu, XC ;
Wang, SH ;
McMurtry, S ;
Kim, DH ;
Platonov, M ;
Koshal, A ;
Hashimoto, K ;
Campbell, WB ;
Falck, JR ;
Michelakis, ED .
CIRCULATION, 2003, 107 (05) :769-776
[3]   EDHF:: bringing the concepts together [J].
Busse, R ;
Edwards, G ;
Félétou, M ;
Fleming, I ;
Vanhoutte, PM ;
Weston, AH .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2002, 23 (08) :374-380
[4]   EFFECT OF DIFFERENT PROSTAGLANDIN SYNTHESIS INHIBITORS ON POST-OCCLUSIVE BLOOD-FLOW IN HUMAN FOREARM [J].
CARLSSON, I ;
WENNMALM, A .
PROSTAGLANDINS, 1983, 26 (02) :241-251
[5]   Vitamin C improves resistance but not conduit artery endothelial function in patients with chronic renal failure [J].
Cross, JM ;
Donald, AE ;
Nuttall, SL ;
Deanfield, JE ;
Woolfson, RG ;
MacAllister, RJ .
KIDNEY INTERNATIONAL, 2003, 63 (04) :1433-1442
[6]   Quantitative aspects of the inhibition by NG-monomethyl-L-arginine of responses to endothelium-dependent vasodilators in human forearm vasculature [J].
Dawes, M ;
Chowienczyk, PJ ;
Ritter, JM .
BRITISH JOURNAL OF PHARMACOLOGY, 2001, 134 (05) :939-944
[7]   Inhibition of cytochrome P4502C9 improves endothelium-dependent, nitric oxide-mediated vasodilatation in patients with coronary artery disease [J].
Fichtlscherer, S ;
Dimmeler, S ;
Breuer, S ;
Busse, R ;
Zeiher, AM ;
Fleming, I .
CIRCULATION, 2004, 109 (02) :178-183
[8]   Cytochrome P4502C is an EDHF synthase in coronary arteries [J].
Fisslthaler, B ;
Popp, R ;
Kiss, L ;
Potente, M ;
Harder, DR ;
Fleming, I ;
Busse, R .
NATURE, 1999, 401 (6752) :493-497
[9]   Endothelium-derived hyperpolarizing factor synthase (cytochrome P4502C9) is a functionally significant source of reactive oxygen species in coronary arteries [J].
Fleming, I ;
Michaelis, UR ;
Bredenkötter, D ;
Fisslthaler, B ;
Dehghani, F ;
Brandes, RP ;
Busse, R .
CIRCULATION RESEARCH, 2001, 88 (01) :44-51
[10]  
Foley RN, 1998, J AM SOC NEPHROL, V9, P267